Rob joined Penn in 2004 following a 19 year career in the pharmaceutical industry in a variety of roles, he holds a BSc in Biochemistry from the University of Manchester. Before moving to Penn Pharmaceutical Services, Rob spent a period working for a medical device supplier as General Sales Manager. Prior to this Rob developed his career with a multinational Pharmaceutical company including managing a successful business development team responsible for winning manufacturing contracts with major pharmaceutical clients. "This is an exciting time to be taking on a role that involves developing new business for Penn, explains Rob! The MBO has presented us as a management team with an enormous opportunity to drive the business forward as we continue to provide market leading services to our clients." "Recent years have seen an unprecedented increase in the outsourcing of manufacturing, pharmaceutical development and clinical support with demand continuing to grow. Penn combines high quality technical expertise within a company whose size and culture ensures great customer focus. "I am looking forward to expanding the number of markets in which Penn provides its unique range of specialised services within the pharmaceutical industry." Penn is a leading provider of outsourced pharmaceutical development services to the international healthcare industry and is one of five companies in Europe to offer development and clinical supply for new drugs. The company’s core business expertise includes a fully integrated product development service, which consists of formulation and analytical development, clinical trial manufacturing, packing and supply management and extensive custom manufacturing capabilities. Penn also offers CMC Consultancy and Qualified Person (QP) Services.